
4.03BUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US53635D2027
CUSIP
53635D202
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
32.44
PEG Ratio
-
Book Value
2.19
Dividend Share
-
Dividend Yield
-
Earnings Share
1.29
Wall Street Target Price
54.38
EPS Estimate Current Year
2.03
EPS Estimate Next Year
2.19
EPS Estimate Current Quarter
0.836
EPS Estimate Next Quarter
0.966
Most Recent Quarter
-
Revenue TTM
450,907,008
Gross Profit TTM
417,276,992
EBITDA
169,768,000
Profit Margin
30.74%
Return On Assets TTM
27.04%
Return On Equity TTM
131.82%
Revenue Per Share TTM
5.148
Qtly Revenue Growth YOY
1842.70%
Diluted Eps TTM
1.29
Qtly Earnings Growth YOY
0.00%
Trailing PE
32.44
Forward PE
11
Price Sales TTM
8.3076
Price Book MRQ
20.6576
Enterprise Value Revenue
8
Enterprise Value EBITDA
22
13.00
6.11%42.15
2.78%8.91
1.48%98.42
0.00%33.21
-1.48%45.90
-1.46%167.45
-1.17%20.75
-0.69%40.91
-0.44%228.00
-0.44%
See which Billionaires own this investment